Paola Ulivi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 5

Top Topics

Metastatic Colorectal Cancer

Ejection Fraction

Top Venues

Journal of oncology

The International journal of biological markers

This page only lists publications with an associated author ORCID identifier.

Publications

Francesca Salani, Maryam Latarani, Stefano Cascinu, Priyadarsini Gangadharannambiar, Lorenzo Fornaro, Caterina Vivaldi, Irene Pecora, Valentina Massa, Giorgia Marisi, Matteo Canale, Paola Ulivi, Mario Scartozzi, Mark Eccleston, Gianluca Masi, Francesco Crea
Predictive significance of circulating histones in hepatocellular carcinoma patients treated with sorafenib. Epigenomics 14 (9) (2022)
Victor Desmond Mandel, Matelda Medri, Ausilia Maria Manganoni, Laura Pavoni, Francesco De Rosa, Simone Ribero, Flavia Foca, Daniele Andreis, Laura Mazzoni, Serena Magi, Francesca Farnetani, Marco Palla, Paola Ulivi, Ignazio Stanganelli
Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications. The Journal of dermatological treatment (2020)
Paola Ulivi
Predictive biomarkers in clinical practice: State of the art and perspectives in solid tumors. The International journal of biological markers 35 (1_suppl) (2020)
Serena De Matteis, Matteo Canale, Alberto Verlicchi, Giuseppe Bronte, Angelo Delmonte, Lucio Crinò, Giovanni Martinelli, Paola Ulivi
Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer. Journal of oncology 2019 (2019)
Andrea Casadei Gardini, Elisa Chiadini, Luca Faloppi, Giorgia Marisi, Angelo Delmonte, Mario Scartozzi, Cristian Loretelli, Alessandro Lucchesi, Devil Oboldi, Alessandra Dubini, Giovanni Luca Frassineti, Paola Ulivi
Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report. BMC cancer 16 (2016)